Search Results - "Bednar, Filip"

Refine Results
  1. 1
  2. 2

    Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice by Collins, Meredith A, Bednar, Filip, Zhang, Yaqing, Brisset, Jean-Christophe, Galbán, Stefanie, Galbán, Craig J, Rakshit, Sabita, Flannagan, Karen S, Adsay, N Volkan, Pasca di Magliano, Marina

    Published in The Journal of clinical investigation (01-02-2012)
    “…Pancreatic cancer is almost invariably associated with mutations in the KRAS gene, most commonly KRASG12D, that result in a dominant-active form of the KRAS…”
    Get full text
    Journal Article
  3. 3

    Survival Benefit of Adjuvant Chemotherapy After Pancreatoduodenectomy for Ampullary Adenocarcinoma: a Propensity-Matched National Cancer Database (NCDB) Analysis by Kamarajah, Sivesh K., Bednar, Filip, Cho, Clifford S., Nathan, Hari

    Published in Journal of gastrointestinal surgery (01-07-2021)
    “…Background The benefit of adjuvant chemotherapy (AC) after pancreatoduodenectomy (PD) for ampullary adenocarcinoma is uncertain. We aimed to evaluate the…”
    Get full text
    Journal Article
  4. 4

    Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance by YAQING ZHANG, WEI YAN, COLLINS, Meredith A, BEDNAR, Filip, RAKSHIT, Sabita, ZETTER, Bruce R, STANGER, Ben Z, IVY CHUNG, RHIM, Andrew D, PASCA DI MAGLIANO, Marina

    Published in Cancer research (Chicago, Ill.) (15-10-2013)
    “…Pancreatic cancer, one of the deadliest human malignancies, is almost invariably associated with the presence of an oncogenic form of Kras. Mice expressing…”
    Get full text
    Journal Article
  5. 5

    The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer by Abel, Ethan V, Kim, Edward J, Wu, Jingjiang, Hynes, Mark, Bednar, Filip, Proctor, Erica, Wang, Lidong, Dziubinski, Michele L, Simeone, Diane M

    Published in PloS one (19-03-2014)
    “…Pancreatic cancer stem cells (CSCs) represent a small subpopulation of pancreatic cancer cells that have the capacity to initiate and propagate tumor…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Metastatic pancreatic cancer is dependent on oncogenic Kras in mice by Collins, Meredith A, Brisset, Jean-Christophe, Zhang, Yaqing, Bednar, Filip, Pierre, Josette, Heist, Kevin A, Galbán, Craig J, Galbán, Stefanie, di Magliano, Marina Pasca

    Published in PloS one (03-12-2012)
    “…Pancreatic cancer is one of the deadliest human malignancies, and its prognosis has not improved over the past 40 years. Mouse models that spontaneously…”
    Get full text
    Journal Article
  8. 8

    Immunotherapy for pancreatic ductal adenocarcinoma by Carpenter, Eileen, Nelson, Sarah, Bednar, Filip, Cho, Clifford, Nathan, Hari, Sahai, Vaibhav, Magliano, Marina Pasca, Frankel, Timothy L.

    Published in Journal of surgical oncology (01-03-2021)
    “…Pancreatic ductal adenocarcinoma (PDAC) remains a lethal cancer with an urgent need for better medical therapies. Efforts have been made to investigate the…”
    Get full text
    Journal Article
  9. 9

    Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma by Proctor, Erica, Waghray, Meghna, Lee, Cheong Jun, Heidt, David G, Yalamanchili, Malica, Li, Chenwei, Bednar, Filip, Simeone, Diane M

    Published in PloS one (20-02-2013)
    “…Bmi1 is an integral component of the Polycomb Repressive Complex 1 (PRC1) and is involved in the pathogenesis of multiple cancers. It also plays a key role in…”
    Get full text
    Journal Article
  10. 10

    Analysis of Predictors of Resection and Survival in Locally Advanced Stage III Pancreatic Cancer: Does the Nature of Chemotherapy Regimen Influence Outcomes? by Bednar, Filip, Zenati, Mazen S., Steve, Jennifer, Winters, Sharon, Ocuin, Lee M., Bahary, Nathan, Hogg, Melissa E., Zeh, Herbert J., Zureikat, Amer H.

    Published in Annals of surgical oncology (01-05-2017)
    “…Background Locally advanced unresectable pancreatic cancer (LAPC) historically portends a poor prognosis. FOLFIRINOX and gemcitabine/nab-paclitaxel have proven…”
    Get full text
    Journal Article
  11. 11

    Pancreatic cancer stem cell biology and its therapeutic implications by Bednar, Filip, Simeone, Diane M.

    Published in Journal of gastroenterology (01-12-2011)
    “…Pancreatic cancer remains one of the most difficult malignancies to treat. Significant developments in our understanding of pancreatic cancer biology have…”
    Get full text
    Journal Article
  12. 12

    Metformin and cancer stem cells: old drug, new targets by Bednar, Filip, Simeone, Diane M

    “…In this issue of the journal, Bao and colleagues report (beginning on page 355) that the antidiabetic drug metformin targets pancreatic cancer stem cells…”
    Get full text
    Journal Article
  13. 13

    Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma by Thompson, Joyce K, Bednar, Filip

    Published in Epigenomes (27-09-2021)
    “…Pancreatic cancer is a molecularly heterogeneous disease. Epigenetic changes and epigenetic regulatory mechanisms underlie at least some of this heterogeneity…”
    Get full text
    Journal Article
  14. 14

    ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis by Wang, Lidong, Yang, Huibin, Abel, Ethan V, Ney, Gina M, Palmbos, Phillip L, Bednar, Filip, Zhang, Yaqing, Leflein, Jacob, Waghray, Meghna, Owens, Scott, Wilkinson, John E, Prasad, Jayendra, Ljungman, Mats, Rhim, Andrew D, Pasca di Magliano, Marina, Simeone, Diane M

    Published in Genes & development (15-01-2015)
    “…The initiation of pancreatic ductal adenocarcinoma (PDA) is linked to activating mutations in KRAS. However, in PDA mouse models, expression of oncogenic…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Pancreatic cancer stem cells and relevance to cancer treatments by Bednar, Filip, Simeone, Diane M.

    Published in Journal of cellular biochemistry (01-05-2009)
    “…Pancreatic cancer continues to be a malignancy with few therapeutic options. The majority of patients that present for an evaluation have locally advanced or…”
    Get full text
    Journal Article
  19. 19

    Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer by Das, Rishi, Hadley, Scott, Sahai, Vaibhav, Bednar, Filip, Evans, Joseph, Lawrence, Theodore, Cuneo, Kyle, Abbott, Madeline R., Schipper, Matt

    Published in Advances in radiation oncology (01-11-2023)
    “…Patients with pancreatic cancer undergoing chemoradiation therapy may experience acute and chronic side effects. We conducted an exploratory analysis of…”
    Get full text
    Journal Article
  20. 20